Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

Journal of the American College of Cardiology
Jeff S HealeyStuart J Connolly

Abstract

This study was designed to identify all randomized clinical trial data evaluating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for the prevention of atrial fibrillation (AF), to estimate the magnitude of this effect and to identify patient subgroups most likely to benefit. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) reduce morbidity and mortality in patients with heart failure, vascular disease, and hypertension. Several reports suggest that they may also prevent the development of AF. A systematic review of the literature was performed to identify all reports of the effect of ACEIs or ARBs on the development of AF. Eligible studies had to be randomized, controlled, parallel-design human trials of an ACEI or ARB that collected data on the development of AF. A total of 11 studies, which included 56,308 patients, were identified: 4 in heart failure, 3 in hypertension, 2 in patients following cardioversion for AF, and 2 in patients following myocardial infarction. Overall, ACEIs and ARBs reduced the relative risk of AF by 28% (95% confidence interval [CI] 15% to 40%, p = 0.0002). Reduction in AF was similar between the two classes of drugs (ACEI: 28%, p = 0...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Mar 16, 1994·JAMA : the Journal of the American Medical Association·Emelia J BenjaminP A Wolf
Apr 29, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Roland E SchmiederP Martus
Jan 20, 2000·The New England Journal of Medicine·Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Jun 7, 2000·Circulation·Hideko NakashimaKikuo Arakawa
Feb 24, 2001·Journal of the American College of Cardiology·S S ChughBernard J Gersh
Oct 31, 2001·Cardiovascular Research·Y ShiJean-Claude Tardif
Dec 20, 2002·JAMA : the Journal of the American Medical Association·ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Dec 1, 1995·Journal of Cardiac Failure·M P Van Den BergK I Lie
Sep 19, 2003·Lancet·K M Fox, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferValsartan in Acute Myocardial Infarction Trial Investigators

Citations

Jan 24, 2009·Medizinische Klinik·Imke DrewitzMitarbeit des Kompetenznetzes Vorhofflimmern (AFNET)
Mar 5, 2008·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Maya GuglinAnne B Curtis
Aug 8, 2012·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Qingyan ZhaoCongxin Huang
Aug 10, 2007·Current Hypertension Reports·Kristian WachtellAnd Paulette A Lyle
Sep 4, 2008·Current Hypertension Reports·Tonje A AksnesSverre E Kjeldsen
Jul 16, 2008·Current Hypertension Reports·Helmy M Siragy
May 12, 2012·Current Hypertension Reports·Athanasios J ManolisLeonidas E Poulimenos
Apr 18, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yuji ShigematsuJitsuo Higaki
Jul 11, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Narihisa MatsuyamaYouici Takeyama
Jan 21, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinpei KimuraYoshifusa Aizawa
Mar 29, 2006·Nature Clinical Practice. Cardiovascular Medicine·Samuel Lévy
Oct 15, 2008·Nature Clinical Practice. Cardiovascular Medicine·Domenico CorradiOttavio Alfieri
Feb 25, 2010·Nature Reviews. Cardiology·Alexander Burashnikov, Charles Antzelevitch
Jul 27, 2010·Nature Reviews. Cardiology·Nadzeya KuzniatsovaGregory Y H Lip
Apr 28, 2010·Nature Reviews. Cardiology·Ashok J ShahMichel Haïssaguerre
Jun 23, 2010·Nature Reviews. Cardiology·Steven A LubitzPatrick T Ellinor
Dec 2, 2006·Nature Reviews. Drug Discovery·Stanley Nattel, Leif Carlsson
Jul 31, 2009·The New England Journal of Medicine·Marcelle D Smit, Isabelle C Van Gelder
Jun 21, 2008·The New England Journal of Medicine·Michael E Cain, Anne B Curtis
Apr 17, 2009·The New England Journal of Medicine·Marcello DisertoriGianni Tognoni
Mar 11, 2011·The New England Journal of Medicine·ACTIVE I InvestigatorsStuart J Connolly
Jul 4, 2012·Antioxidants & Redox Signaling·Min ZhangAjay M Shah
May 14, 2010·Rejuvenation Research·James W Larrick, Andrew Mendelsohn
Dec 9, 2008·British Medical Bulletin·Abhay BajpaiA John Camm
Nov 16, 2010·Cardiovascular Research·Anne Margreet De JongIsabelle C Van Gelder
Jul 31, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Andreas BollmannS Bertil Olsson
Dec 17, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Marcelle D Smit, Isabelle C Van Gelder
Jun 18, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Paulus KirchhofGünter Breithardt
Aug 12, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Finn HegbomPal Smith
Jan 13, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Dimpi PatelAndrea Natale
Feb 23, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Richard J Folkeringa, Harry J G M Crijns
Sep 14, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Luigi SciarraLeonardo Calò
Sep 30, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·A John CammESC Committee for Practice Guidelines
Nov 16, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Tong LiuGuangping Li
Dec 15, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Takeshi YamashitaJ-RHYTHM II Investigators

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.